PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
89.98%
Some net income increase while CRON.TO is negative at -2441.03%. John Neff would see a short-term edge over the struggling competitor.
-14.14%
Both reduce yoy D&A, with CRON.TO at -45.20%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
85.44%
Deferred tax of 85.44% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
2.07%
SBC growth while CRON.TO is negative at -1.23%. John Neff would see competitor possibly controlling share issuance more tightly.
241.46%
Less working capital growth vs. CRON.TO's 6552.09%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-222.19%
AR is negative yoy while CRON.TO is 161.15%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
93.32%
Some inventory rise while CRON.TO is negative at -22.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
1141.22%
AP growth well above CRON.TO's 233.32%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
304.96%
Growth well above CRON.TO's 155.05%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-92.82%
Negative yoy while CRON.TO is 1586.16%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
334.00%
Operating cash flow growth below 50% of CRON.TO's 9288.52%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-1347.61%
Both yoy lines negative, with CRON.TO at -451.38%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
137.44%
Acquisition spending well above CRON.TO's 30.24%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
234.95%
Some yoy expansion while CRON.TO is negative at -23.75%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-100.00%
Both yoy lines are negative, with CRON.TO at -28.05%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
14093.33%
We have some outflow growth while CRON.TO is negative at -32.53%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-65.16%
Both yoy lines negative, with CRON.TO at -48.03%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2637.45%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-100.00%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
100.00%
We have some buyback growth while CRON.TO is negative at -608.87%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.